<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-76198</identifier>
<setSpec>1132-8460</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Hypercalcemia as a medical emergency</dc:title>
<dc:description xml:lang="en">Hypercalcemia is a metabolic disorder of calcium that may cause systemic complications when is produced suddenly or above 14.5 mg/dl. It is considered as a medical emergency that appears more frequently at advanced malignant disease, usually through the activation of parathyroid hormone-related protein. It should be treated promptly and an intensive therapy with fluids and intravenous bisphosphonates are the keys to achieve metabolic restoration. At present, zoledronic acid is considered the most effective bisphosphonate for acute hypercalcemia(AU)</dc:description>
<dc:creator>Nuevo-González, J. A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La hipercalcemia es una alteración del metabolismo del calcio que, producida bruscamente o por encima de 14,5 mg/dl, puede provocar complicaciones sistémicas que comprometan la vida del paciente. Es una urgencia médica que se presenta con mayor frecuencia en la enfermedad tumoral avanzada, generalmente a través de la activación de la proteína relacionada con la hormona paratiroidea. Se debe iniciar un tratamiento inmediato, siendo la sueroterapia intensiva y los bifosfonatos intravenosos las claves para conseguir una restauración metabólica rápida. Zolendronato se considera actualmente el bifosfonato más eficaz para la hipercalcemia aguda(AU)</dc:description>
<dc:source>Rev. esp. enferm. metab. óseas (Ed. impr.);18(3): 51-55, jul.-sept. 2009.</dc:source>
<dc:identifier>ibc-76198</dc:identifier>
<dc:title xml:lang="es">Hipercalcemia como urgencia médica</dc:title>
<dc:subject>^d32988^s22073</dc:subject>
<dc:subject>^d4220^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7114^s22016</dc:subject>
<dc:subject>^d2164^s22016</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d7114^s22012</dc:subject>
<dc:subject>^d7114^s22067</dc:subject>
<dc:subject>^d2164^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>200909</dc:date>
</metadata>
</record>
</ibecs-document>
